Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Med Trop Sante Int ; 1(1)2021 03 31.
Artículo en Francés | MEDLINE | ID: mdl-35586643

RESUMEN

Objective: In sub-Saharan Africa where 90% of malaria cases are concentrated, the control of this disease constitutes a major challenge whose diagnosis by thick and thin smear deserves to be exact and reproducible. The purpose of this study is to assess the performance of thick/thin blood smear in order to improve its implementation process. Material and methods: This was a descriptive and analytical study that took place from May to June 2017 and involved participating laboratories (PL) coming from public, liberal and confessional sectors in Lomé. A set of 13 blood smear slides of variable parasite densities (PD) with assigned values (AV) of parasite densities and the Plasmodium species assigned was used. The criterion for establishing the parasite densities compliance interval was assigned values ± 25% and the performance rates were compared to the 80% recommended by the WHO for Africa region. Results: 41.9% (13/31) of the PLs had a compliance rate greater than 80% including four with a performance of 100% for the ability to identify the Plasmodium species. For the parasitaemia < 100/µl, 51.6% of participating laboratories had a performance rate less than 80% and for parasitaemia > 2000/µl, 100% of these laboratories had a performance rate greater than 80%. Conclusion: The evaluated laboratories had insufficient ability for the identification of Plasmodium falciparum and the correct estimation of low parasitaemia. A need to strength the technical skills, adapted to the context of low parasitaemia are essential to improve the biological diagnosis of malaria in Togo.


Asunto(s)
Malaria , Plasmodium , Humanos , Malaria/diagnóstico , Microscopía , Parasitemia/diagnóstico , Plasmodium falciparum , Togo/epidemiología
2.
Bull Soc Pathol Exot ; 108(3): 181-7, 2015 Aug.
Artículo en Francés | MEDLINE | ID: mdl-25476256

RESUMEN

The aim of this study is to verify the level of transmission of lymphatic filariasis three years after stopping mass drug treatment in the 7 endemic districts in Togo. The survey was conducted in 2012 in Togo's 7 endemic districts grouped into four evaluation units (EU) using the WHO-recommended transmission assessment survey (TAS) protocol. Children aged 6-7 years were screened for Wuchereria bancofti antigen using the immunochromatographic card (ICT) method. A cluster sampling method was used to select eligible children in schools as the net primary-school enrolment ratio is greater than or equal to 75% in each of the four EUs. The number of children and schools to be selected in each EU, the randomization list for the selection of these children and the critical cut-off number of positive cases not to exceed were automatically generated using the Survey Sample Builder (SSB) tool, (NTD Support Center, Atlanta, Ga, USA). For confirmation, positive cases were subsequently tested for microfilaremia using nocturnal thick blood smear and for filarial antigen using Og4C3 antigen ELISA (TropBio ELISA Kit®, Townsville, Queensland, Australia). An EU is considered to have passed the test successfully (it is assumed that transmission can no longer be sustained), when the number of positive cases is below the critical cut-off number set by the SSB, which is roughly equivalent to 2% prevalence. Of the 1 706 children surveyed in Kpendjal-Tone's EU, 1 549 in Binah-Doufelgou's EU, 1 550 in Kozah's EU and the 1 575 in Amou-Haho's EU, 8 (0.46%), 1 (0.08%), 0 (0.00%) and 4 (0.25%) ICT positive cases respectively were detected. The number of positive ICT tests was well below 18, the critical cut number for each of the 4 EUs. All 13 ICT positive cases tested negative for nocturnal microfilaremia and Og4C3 ELISA. We conclude that all four EU passed the TAS with success, and the transmission of Wuchereria bancrofti is no longer likely to be sustained in the 7 endemic districts in Togo 3 years after stopping the MDA. A new TAS will be carried out in 2015, after which, if the results are still good, the country will submit a dossier to WHO for verification of the elimination of lymphatic filariasis.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Filariasis Linfática/epidemiología , Enfermedades Endémicas , Programas de Gobierno , Promoción de la Salud , Ivermectina/uso terapéutico , Albendazol/administración & dosificación , Animales , Antihelmínticos/administración & dosificación , Antígenos Helmínticos/sangre , Niño , Cromatografía de Afinidad/instrumentación , Estudios Transversales , Filariasis Linfática/diagnóstico , Filariasis Linfática/prevención & control , Filariasis Linfática/transmisión , Enfermedades Endémicas/prevención & control , Femenino , Promoción de la Salud/organización & administración , Encuestas Epidemiológicas , Humanos , Ivermectina/administración & dosificación , Masculino , Tamizaje Masivo , Microfilarias/aislamiento & purificación , Parasitemia/diagnóstico , Parasitemia/parasitología , Guías de Práctica Clínica como Asunto , Evaluación de Programas y Proyectos de Salud , Muestreo , Servicios de Salud Escolar , Instituciones Académicas , Togo/epidemiología , Organización Mundial de la Salud , Wuchereria bancrofti/inmunología , Wuchereria bancrofti/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda